Russian state continues to keep domestic drug market under control

Drug imports to Russia are ongoing almost in the same volumes as in the past, despite the current situation in Russia, according to recent statements by Viktor Dmitriev, general director of the Association of Russian Pharmaceutical Manufacturers (ARPM) and some independent local analysts in the field of pharmaceuticals.

Mr Dmitriev said in an interview with some Russian media, there are reductions in the supplies of some drugs’ categories, which is mainly due to an increase in the cost of logistics.

According to him, drugs that are produced in Russia receive some additional competitive advantages, which means that imports of medicines with the same international generic name becomes less profitable to Russia due to expensive and lengthy logistics.